iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases | MicrobiomeTrials

← Back to trials

NCT03549754

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

RecruitingOBSERVATIONAL

Trial Details

Start: 2018-02-17Est. Completion: 2030-12-31

Enrollment target: 35,000 participants

Locations

Research Site, Fortaleza, Ceará, Brazil
Research Site, Colatina, Espírito Santo (ES), Brazil
Research Site, Salvador, Estado de Bahia, Brazil
Research Site, Brasília, Federal District, Brazil
Research Site, Poços de Caldas, Minas Gerais, Brazil
Research Site, Campina Grande do Sul, Paraná, Brazil
Research Site, Curitiba, Paraná, Brazil
Research Site, Teresina, Piauí (PI), Brazil
Research Site, Santa Cruz do Sul, Rio Grande Do Sul (RS), Brazil
Research Site, Goiânia, State of Goias, Brazil
Research Site, Joinville, State of Santa Catarina, Brazil
Research Site, Bragança Paulista, São Paulo, Brazil
Research Site, São Caetano do Sul, São Paulo, Brazil
Research Site, São Paulo, Brazil
Research Site, São Paulo, Brazil
Research Site, Providencia, Santiago Metropolitan, Chile
Research Site, San José, Costa Rica
Research Site, Abidjan, Côte d’Ivoire
Research Site, Alexandria, Egypt
Research Site, Cairo, Egypt
Research Site, Giza, Egypt
Research Site, Tbilisi, Georgia
Research Site, Kumasi, Ghana
Research Site, Wan Chai, Hong Kong
Research Site, Ahmedabad, India
Research Site, Kolkata, India
Research Site, Mumbai, India
Research Site, Sulaymaniyah, Iraq
Research Site, Aktobe, Kazakhstan
Research Site, Almaty, Kazakhstan
Research Site, Almaty, Kazakhstan
Research Site, Almaty, Kazakhstan
Research Site, Almaty, Kazakhstan
Research Site, Nairobi, Kenya

Contact

AstraZeneca Clinical Study Information Centerinformation.center@astrazeneca.com 1-877-240-9479

Other microbiome trials you might be interested in

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseRecruiting

Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis

Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …

Bethesda, United StatesEst. completion Jun 1, 2036

Effect of Digital-Supported Foot Care Education in Individuals With Type 2 DiabetesRecruiting

Type 2 Diabetes Mellitus (T2DM)

This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledg…

Siirt, Turkey (Türkiye)Est. completion Jul 15, 2027

Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.